Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK
Saved in:
| Published in: | Cell & Bioscience |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868554029812940801 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Cell & Bioscience |
| description | |
| discipline_display | Bioengineering |
| discipline_facet | Bioengineering |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:94107 |
| institution | FRELIP |
| journal_source_facet | Cell & Bioscience |
| last_indexed | 2026-06-20T21:46:24.352Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK Bioengineering General Bioengineering |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Bioengineering General Bioengineering |
| subject_facet | Bioengineering General Bioengineering |
| title | Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK |
| title_alt | Corrección: Dapagliflozina atenúa la disfunción cardíaca y el daño oxidativo inducidos por hipoxia/reoxigenación mediante la modulación de AMPK Correction : La dapagliflozine atténue la dysfonction cardiaque et les dommages oxydatifs induits par l'hypoxie/réoxygénation via la modulation de l'AMPK Correção: Dapagliflozina atenua a disfunção cardíaca e o dano oxidativo causados por hipóxia/reoxigenação através da modulação de AMPK |
| title_auth | Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK |
| title_es_txt | Corrección: Dapagliflozina atenúa la disfunción cardíaca y el daño oxidativo inducidos por hipoxia/reoxigenación mediante la modulación de AMPK |
| title_fr_txt | Correction : La dapagliflozine atténue la dysfonction cardiaque et les dommages oxydatifs induits par l'hypoxie/réoxygénation via la modulation de l'AMPK |
| title_full | Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK |
| title_fullStr | Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK |
| title_full_unstemmed | Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK |
| title_pt_txt | Correção: Dapagliflozina atenua a disfunção cardíaca e o dano oxidativo causados por hipóxia/reoxigenação através da modulação de AMPK |
| title_short | Correction: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK |
| title_sort | correction: dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of ampk |
| topic | Bioengineering General Bioengineering |
| url | https://link.springer.com/article/10.1186/s13578-026-01606-y |